title: Low adhesion receptor levels on circulating platelets in patients with lymphoproliferative diseases before receiving Navitoclax (ABT-263).
authors: Jianlin
authors: J
authors: Qiao
authors: Simone M
authors: SM
authors: Schoenwaelder
authors: Kylie D
authors: KD
authors: Mason
authors: Huy
authors: H
authors: Tran
authors: Amanda K
authors: AK
authors: Davis
authors: Zane S
authors: ZS
authors: Kaplan
authors: Shaun P
authors: SP
authors: Jackson
authors: Benjamin T
authors: BT
authors: Kile
authors: Robert K
authors: RK
authors: Andrews
authors: Andrew W
authors: AW
authors: Roberts
authors: Elizabeth E
authors: EE
authors: Gardiner
mesh_terms: D000814:Aniline Compounds / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism*; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000188:drug therapy* / Q000378:metabolism*; D008562:Membrane Glycoproteins / Q000378:metabolism*; D019038:Platelet Glycoprotein GPIb-IX Complex; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000037:antagonists & inhibitors; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D000814:Aniline Compounds; D008562:Membrane Glycoproteins; D019038:Platelet Glycoprotein GPIb-IX Complex; D019253:Proto-Oncogene Proteins c-bcl-2; D013449:Sulfonamides; C094990:adhesion receptor; C528561:navitoclax